Why Flexion Therapeutics Stock Is Flying Higher Today
A key FDA decision could pave the way for higher sales of the company's flagship drug.
Flexion Therapeutics
FLXN
FLXN
$17.13
$0.60
3.6%
Price as of February 21, 2020, 12:02 p.m. EST
View Interactive FLXN Charts
FLEXION THERAPEUTI
Interactive Chart
News & Analysis: Flexion Therapeutics
Flexion Therapeutics Inc (FLXN) Q3 2019 Earnings Call Transcript
FLXN earnings call for the period ending September 30, 2019.
3 Healthcare Stocks With Rising Expectations
For a few companies, the second half of 2019 will probably work out better than investors dared hope for earlier this year.
Flexion Therapeutics, Inc. (FLXN) Q2 2019 Earnings Call Transcript
FLXN earnings call for the period ending June 30, 2019.
These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
Flexion Therapeutics, Inc. (FLXN) Q1 2019 Earnings Call Transcript
FLXN earnings call for the period ending March 31, 2019.
Here's Why Flexion Therapeutics Jumped as Much as 18.4% Today
The pharma company announced first-quarter 2019 operating results.
Flexion Therapeutics Inc (FLXN) Q4 2018 Earnings Conference Call Transcript
FLXN earnings call for the period ending December 31, 2018.
Here's Why Flexion Therapeutics Rose 29.8% in January
The company reported preliminary full-year 2018 results and set expectations for a solid year of growth in 2019.
Here's Why Flexion Therapeutics Jumped 20.5% in November
The small-cap biopharma announced third-quarter 2018 operating results and a business update.
